dihydroxyphenylalanine has been researched along with Aortic Stenosis in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunter, KR | 1 |
| Hollman, A | 1 |
| Laurence, DR | 1 |
| Stern, GM | 1 |
| Jenkins, RB | 1 |
| Mendelson, SH | 1 |
| Lamid, S | 1 |
| Klawans, HL | 1 |
2 other studies available for dihydroxyphenylalanine and Aortic Stenosis
| Article | Year |
|---|---|
Levodopa in Parkinsonian patients with heart-disease.
Topics: Aged; Aortic Valve Stenosis; Arrhythmias, Cardiac; Cardiomegaly; Coronary Disease; Dihydroxyphenylal | 1971 |
Levodopa therapy of patients with Parkinsonism and heart disease.
Topics: Aged; Angina Pectoris; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Arrhythmias, Cardiac; Coronary | 1972 |